Evidence-Based Complementary and Alternative MedicineVolume 2012 (2012), Article ID 728281, 7 pagesdoi:10.1155/2012/728281

Research Article

A Therapeutic Approach for Wound Healing by Using Essential Oils of Cupressus and Juniperus Species Growing in Turkey

Ibrahim Tumen,¹ Ipek Süntar,² Hikmet Keleş,³ and Esra Küpeli Akkol²

¹Department of Forest Products Chemistry, Faculty of Forestry, Bartin University, 74100 Bartin, Turkey²Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, Etiler, 06330 Ankara, Turkey³Department of Pathology, Faculty of Veterinary Medicine, Afyon Kocatepe University, 03200 Afyonkarahisar, Turkey

Received 8 June 2011; Accepted 16 July 2011

Academic Editor: Saringat Hj. Baie

Copyright © 2012 Ibrahim Tumen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Juniperus and Cupressus genera are mainly used as diuretic, stimulant, and antiseptic, for common cold and wound healing in Turkish folk medicine. In the present study, essential oils obtained from cones of Cupressus and berries of Juniperus were evaluated for their wound healing and anti-inflammatory effects. In vivo wound healing activity was evaluated by linear incision and circular excision experimental wound models, assessment of hydroxyproline content, and subsequently histopathological analysis. The healing potential was comparatively assessed with a reference ointment Madecassol. Additionally acetic-acid-induced capillary permeability test was used for the oils' anti-inflammatory activity. The essential oils of J. oxycedrus subsp. oxycedrus and J. phoenicea demonstrated the highest activities, while the rest of the species did not show any significant wound healing effect. The experimental study revealed that J. oxycedrus subsp. oxycedrus and J. phoenicea display remarkable wound healing and anti-inflammatory activities, which support the folkloric use of the plants.

1. Introduction

Juniperus L. (Cupressaceae) has almost 70 species throughout the world and are mostly distributed in the Northern Hemisphere [1]. The widespread areas extend from Japan and East Asia to Europe, as well as from North and East Africa to North America. In Turkey, the Juniperus genus is represented by 10 taxa under seven speciess and has also been used by Anatolian people since ancient times. Fruits of Juniperus species are used to produce pekmez (a traditional Turkish fruit concentrate), which is rich in nutritional constituents [2]. Juniper berries are used in Northern European countries to impart sharp and clear flavour to the meat dishes [3, 4]. The coniferous parts and leaves of Juniperus are utilized in medicine as an antihelmintic, diuretic, stimulant, and antiseptic and for wound healing. J. excelsa is used against tuberculosis and jaundice [5]. The literature survey indicates that the major phenolic constituents in extracts of Juniperus species are lignans, coumarins, sesquiterpenes, abietane, labdane and pimarane diterpenes, flavonoids, biflavonols, flavone glycosides, and tannins [1].

The genus Cupressus is one of several genera within the family Cupressaceae. Based on genetic and morphological analysis, the Cupressus is found in the Cupressoideae subfamily [6]. They are widespread in the northern hemisphere, including western North America, Central America, north-west Africa, the Middle East, the Himalaya, southern China, and north Vietnam. They are evergreen trees or large shrubs, growing to 5–40 m tall. In Turkish folk medicine, fruits of Cupressus sempervirens are used to treat common cold and cough [7]. In previous studies, the major constituents have been identified in Cupressus species as α-pinene and Δ-3-carene [8]. The leaves and fruits of this plant are quite rich in tannins and flavonoids but they are free from alkaloids and low in saponins [9].

The aim of the present study is to evaluate the wound healing activity of the oils from cones of Cupressus sempervirens var. horizontalis and C. sempervirens var. pyramidalis and berries of J. communis, J. excelsa, J. foetidissima, J. oxycedrus, and J. phoenicea by means of in vivo circular excision and linear incision wound models and anti-inflammatory activity.

2. Materials and Methods

2.1. Plant Material

Berries and cones of 5 different Juniper species and 2 different varieties of Cypress belonging to Cupressaceae family natively growing in Turkey were chosen as the study material. Specimens were taken from each species as 1 kg weight from their growth sites and stored at −24°C until analysis [10]. Species names, sampling site, local name, collection date, and altitude of all specimens are listed in Table 1.

Table 1: Sampling site, local name, date, and altitude of the tree species.

Species
Sampling site
Local name
Collection date
Altitude

Cupressus sempervirens var. horizontalis
Antalya-Turkey
Dallı Servi
October, 2010
670 m

Cupressus sempervirens var. pyramidalis
Antalya-Turkey
Piramid Servi
October, 2010
650 m

Juniperus communis L. subsp. nana Syme.
Keltepe-Karabük
Bodur Ardıç
September, 2010
1,210 m

Juniperus excelsa Bieb.
Silifke-Mersin
Boylu Ardıç
October, 2010
220 m

Juniperus foetidissima Willd.
Beypazarı-Ankara
Kokulu Ardıç
October, 2010
240 m

Juniperus oxycedrus L. subsp. oxycedrus
Keltepe-Karabük
Katran Ardıcı
September, 2010
1,200 m

Juniperus phoenicea L.
Bodrum-Yokusbasi
Finike Ardıcı
September, 2010
170 m

2.2. Hydrodistillation

The essential oils of each sample were obtained by hydrodistillation with a Clevenger apparatus using 250 g (partially crushed) of fresh berries and cones. The essential oils were collected for 3 h and dried over anhydrous sodium sulphate and under refrigeration in a sealed vial until required [11, 12].

2.3. Biological Activity Tests

2.3.1. Animals

Male, Sprague-Dawley rats (160–180 g) and Swiss albino mice (20–25 g) were purchased from the animal breeding laboratory of Saki Yenilli (Ankara, Turkey).

The animals were left for 3 days at room conditions for acclimatization. They were maintained on standard pellet diet and water ad libitum throughout the experiment. A minimum of six animals were used in each group. Throughout the experiments, animals were processed according to the suggested European ethical guidelines for the care of laboratory animals.

2.3.2. Preparation of Test Samples for Bioassay

Incision and excision wound models were used to evaluate the wound healing activity. For the in vivo wound models, test samples were prepared in an ointment base (vehicle) consisting of glycol stearate, 1, 2 propylene glycol, liquid paraffin (3 : 6 : 1) in 1% concentration. 0.5 g of each test ointment was applied topically on the wounded site immediately after wound was created by a surgical blade.

The animals of the vehicle group were treated with the ointment base only, whereas the animals of the reference drug group were treated with 0.5 g of Madecassol (Bayer, 00001199). Madecassol contains 1% extract of Centella asiatica.

For the assessment of anti-inflammatory activity, test samples were given orally to test animals after suspending in a mixture of distilled H₂O and 1% Tween 80. The control group animals received the same experimental handling as those of the test groups except that the drug treatment was replaced with appropriate volumes of dosing vehicle. Indomethacin (10 mg/kg) in 1% Tween 80 was used as reference drug.

2.3.3. Wound Healing Activity

Linear Incision Wound ModelAnimals, seven rats in each group, were anaesthetized with 0.15 cc Ketalar [13], and the hairs on the dorsal part of the rats were shaved and cleaned with 70% alcohol. Two 5 cm length linear-paravertebral incisions were made with a sterile blade through the shaved skin at the distance of 1.5 cm from the dorsal midline on each side. Three surgical sutures were placed each 1 cm apart.The ointments prepared with test samples, the reference drug (Madecassol) or ointment base (glycol stearate: propylene glycol: liquid paraffin (3 : 6 : 1)) were topically applied on the dorsal wounds in each group of animals once daily throughout 9 days. All the sutures were removed on the last day, and tensile strength of previously wounded and treated skin was measured by using a tensiometer (Zwick/Roell Z0.5, Germany) [14, 15].

Circular Excision Wound ModelThis model was used to monitor wound contraction and wound closure time. Each group of animals (seven animals in each) was anaesthetized by 0.01 cc Ketalar. The back hairs of the mice were depilated by shaving. The circular wound was created on the dorsal interscapular region of each animal by excising the skin with a 5 mm biopsy punch; wounds were left open (Tramontina, Machado, Nogueira Filho Gda, Kim, Vizzioli & Toledo, 2002). Test samples, the reference drug (Madecassol, Bayer) and the vehicle ointments were applied topically once a day till the wound was completely healed. The progressive changes in wound area were monitored by a camera (Fuji, S20 Pro, Japan) every other day. Later on, wound area was evaluated by using AutoCAD program. Wound contraction was calculated as percentage of the reduction in wounded area. A specimen sample of tissue was isolated from the treated skin of each group of mice for the histopathological examination [16].

2.3.4. Hydroxyproline Estimation

Tissues were dried in hot air oven at 60–70°C till consistent weight was achieved. Afterwards, samples were hydrolyzed with 6 N HCl for 4 hours at 130°C. The hydrolyzed samples were adjusted to pH 7 and subjected to chloramine T oxidation. The coloured adduct formed with Ehrlich reagent at 60°C was read at 557 nm [17]. Standard hydroxyproline was also run and values reported as mg/g dry weight of tissue [18].

2.3.5. Histopathology

The skin specimens from each group were collected at the end of the experiment. Samples were fixed in 10% buffered formalin, processed, and blocked with paraffin and then sectioned into 5 micrometer sections and stained with hematoxylin & eosin (HE) and Van Gieson (VG) stains. The tissues were examined by light microscope (Olympus CX41 attached Kameram Digital Image Analyze System) and graded as mild (+), moderate (++), and severe (+++) for epidermal or dermal remodeling. Re-epithelization or ulcer in epidermis, fibroblast proliferation, mononuclear and/or polymorphonuclear cells, neovascularization, and collagen depositions in dermis were analyzed to score the epidermal or dermal remodeling. At the end of the examination, wound healing phases—inflammation, proliferation, and remodeling—were determined for all groups.

2.3.6. Anti-Inflammatory Activity

Acetic-Acid-Induced Increase in Capillary PermeabilityEffect of the test samples on the increased vascular permeability induced by acetic acid in mice was determined according to Whittle method [19] with some modifications [20]. Each test sample was administered orally to a group of 10 mice in 0.2 mL/20 g body weight. Thirty minutes after the administration, the tail of each animal was injected with 0.1 mL of 4% Evans blue in saline solution (intravenous) and then we waited for 10 min. Then, 0.4 mL of 0.5% (v/v) AcOH was injected intraperitoneally. After 20 min incubation, the mice were killed by dislocation of the neck, and the viscera were exposed and irrigated with distilled water, which was then poured into 10 mL volumetric flasks through glass wool. Each flask was made up to 10 mL with distilled water, 0.1 mL of 0.1 N NaOH solution was added to the flask, and the absorption of the final solution was measured at 590 nm (Beckmann Dual Spectrometer; Beckman, Fullerton, Calif, USA). A mixture of distilled water and 0.5% CMC was given orally to control animals, and they were treated in the same manner as described above.

2.3.7. Statistical Analysis of the Data

The data on percentage anti-inflammatory and wound healing was statistically analyzed using one-way analysis of variance (ANOVA). The values of were considered statistically significant.

Histopathologic data were considered to be nonparametric; therefore, no statistical tests were performed.

3. Results and Discussion

In the present study, wound healing and anti-inflammatory effects of the oils obtained from Cupressus sempervirens var. horizontalis, C. sempervirens var. pyramidalis J. communis, J. excelsa, J. foetidissima, J. oxycedrus, and J. phoenicea were evaluated. The oils were mixed with glycol stearate, 1,2 propylene glycol, liquid paraffin (3 : 6 : 1) in 1% concentration for the assessment of the wound healing activity. Linear incision and circular excision experimental wound models were employed. Moreover, skin samples were evaluated histopathologically. The experimental results are given in Tables 2–6.

Table 2: Effects of the essential oils from C. sempervirens var. horizontalis, C. sempervirens var. pyramidalis, J. communis, J. excelsa, J. foetidissima, J. oxycedrus, and J. phoenicea on linear incision wound model.

Material
Statistical mean ± SEM (tensile strength %)

Vehicle
13.24 ± 2.25 (9.1)

Negative control
12.14 ± 2.54—

Cupressus sempervirens var. horizontalis
14.51 ± 2.17 (9.6)

Cupressus sempervirens var. pyramidalis
14.27 ± 2.09 (7.8)

J. communis subsp. nana
13.82 ± 2.04 (4.4)

Juniperus excelsa
15.27 ± 2.43 (15.3)

Juniperus foetidissima
14.66 ± 1.86 (10.7)

Juniperus oxycedrus subsp. oxycedrus
17.41 ± 2.19(31.5)**

Juniperus phoenicea
18.05 ± 2.26 (36.3)**

Madecassol
19.87 ± 1.41 (50.1)***

* ; ** ; *** ; SEM: Standard error of the mean. Percentage of tensile strength values: vehicle group was compared to negative control group; the oils and the reference material were compared to vehicle group.

Table 3: Effects of the essential oils from C. sempervirens var. horizontalis, C. sempervirens var. pyramidalis, J. communis, J. excelsa, J. foetidissima, J. oxycedrus, and J. phoenicea on circular excision wound model.

Material
Wound area ± SEM (contraction %)

0
2
4
6
8
10
12

Vehicle
19.55 ± 2.09
17.98 ± 2.20 (2.55)
16.54 ± 2.11 —
14.89 ± 1.95 —
9.55 ± 1.56 (9.51)
6.31± 1.16 (8.42)
2.97 ± 0.87 (5.41)

Negative Control
19.43 ± 2.15
18.45 ± 2.23
16.42 ± 2.17
14.72 ± 1.91
10.51 ± 1.75
6.89 ± 1.23
3.14 ± 1.49

C. sempervirens var. horizontalis
19.40 ± 2.13
17.56 ± 1.40 (2.34)
16.02 ± 1.50 (3.14)
14.91 ± 1.62 —
9.57 ± 1.40 —
5.86 ± 1.32 (7.13)
3.56 ± 0.69 —

C. sempervirens var. pyramidalis
20.03 ± 2.12
17.90 ± 1.91 (0.44)
16.69 ± 1.92 —
14.92 ± 1.60 —
8.84 ± 1.67 (7.43)
7.08 ± 1.12 —
2.59 ± 0.84 (12.79)

J. communis subsp. nana Syme.
19.55 ± 2.22
17.81 ± 1.81 (5.56)
16.75 ± 1.80 —
15.16 ± 1.87 —
9.57 ± 1.74 —
6.02 ± 0.99 (4.60)
3.04 ± 0.89 —

J. excelsa
19.50 ± 2.16
14.99 ± 1.78 (16.63)
13.24 ± 2.09 (19.95)
11.26 ± 1.70 (24.38)
7.39 ± 1.58 (22.62)
5.47 ± 1.07 (13.31)
2.44 ± 0.90 (17.85)

J. foetidissima
19.96 ± 2.51
16.16 ± 1.89 (10.12)
14.02 ± 1.78 (15.24)
13.49 ± 1.71 (9.40)
9.09 ± 1.54 (4.82)
6.10 ± 1.27 (3.33)
2.49 ± 1.05 (16.16)

J. oxycedrus subsp. oxycedrus
19.41 ± 2.08
17.51 ± 1.92 (2.61)
16.02 ± 1.70 (6.05)
12.62 ± 1.63 (15.25)
6.03 ± 1.03 (36.86)*
3.85 ± 0.96 (38.99)*
1.69 ± 0.60 (43.10)*

J. phoenicea
19.59 ± 2.19
16.46 ± 2.54 (8.45)
14.02 ± 1.96 (15.24)
11.97 ± 1.86 (19.61)
7.44 ± 1.39 (22.09)
4.21 ± 1.28 (33.28)*
1.76 ± 0.61 (40.74)*

Madecassol
19.68 ± 2.03
14.46 ± 1.83 (19.58)
11.77 ± 1.45 (28.84)
8.76 ± 1.21 (41.17)**
4.74 ± 0.89 (50.37)**
2.12 ± 0.31 (66.40)***
0.00 ± 0.00 (100.00)***

* ; ** ; *** ; SEM: standard error of the mean. Percentage of contraction values: vehicle group was compared to negative control group; the oils and the reference material were compared to vehicle group.

Table 4: Effect of topical treatment of test ointments for 7 days on hydroxyproline content.

Material
Hydroxyproline (mg/g) ± SEM

Vehicle
20.21 ± 2.43

Negative Control
19.25 ± 2.67

C. sempervirens var. horizontalis
18.3 ± 2.41

C. sempervirens var. pyramidalis
25.9 ± 3.17

J. communis subsp. nana
24.3 ± 3.52

J. excelsa
29.5 ± 3.01

J. foetidissima
21.8 ± 2.54

J. oxycedrus subsp. oxycedrus
50.8 ± 2.44**

J. phoenicea
44.3 ± 2.81*

Madecassol
75.6 ± 2.95***

* ; ** ; *** ; SEM: standard error of the mean.

Table 5: Wound healing processes and healing phases of the vehicle, negative control, test ointments, and Madecassol-administered animals.

Groups
Wound healing processes

Vehicle
S
U
RE
FP
CD
MNC
PMN
NV

Negative control
++/+++
+++
—
++/+++
++
+++
++/+++
++

C. sempervirens var. horizontalis
++/+++
++/+++
—
++/+++
++
++
++/+++
++/+++

C. sempervirens var. pyramidalis
++
++/+++
—
++
++
+/++
++
++

J. communis subsp. nana Syme.
++/+++
++/+++
—
++/+++
++
+/++
++
+++

J. excelsa
++/+++
++/+++
—
++
+/++
++
++
+/++

J. foetidissima
+/++
+/++
−/+
++
+/++
+/++
+/++
++

J. oxycedrus subsp. oxycedrus
++
+/++
−/+
++
+/++
+/++
+/++
+/++

J. phoenicea
+/++
+/++
−/+
++
+/++
+/++
+/++
++

Madecassol
+/++
−/+
+
++
+/++
+
+/++
+/++

HE- and VG-stained sections were scored as mild (+), moderate (++), and severe (+++) for epidermal and/or dermal remodeling. S: scab, U: ulcer, RE: re-epithelization, FP: fibroblast proliferation, CD: collagen depositions, MNC: mononuclear cells, PMN: polymorphonuclear cells, NV: neovascularization, I: inflammation phase, P: proliferation phase, and R: remodeling phase.

Table 6: Inhibitory effect of the essential oils from C. sempervirens var. horizontalis, C. sempervirens var. pyramidalis, J. communis, J. excelsa, J. foetidissima, J. oxycedrus, and J. phoenicea on acetic-acid-induced increased capillary permeability.

Material
Dose (mg/kg)
Evans blue concentration (g/mL) ± SEM
Inhibition (%)

Control

10.69 ± 0.86

Cupressus sempervirens var. horizontalis
100
10.40 ± 0.95
2.7

200
10.12 ± 0.74
5.3

Cupressus sempervirens var. pyramidalis
100
10.75 ± 0.87
—

200
11.16 ± 0.91
—

Juniperus communis ssp. nana
100
10.13 ± 0.79
5.2

200
10.01 ± 0.38
6.4

Juniperus excelsa
100
10.57 ± 0.88
1.1

200
9.04 ± 0.85
15.4

Juniperus foetidissima
100
12.27 ± 0.95
—

200
11.25 ± 0.99
—

Juniperus oxycedrus ssp. oxycedrus
100
8.82 ± 0.76
17.5

200
7.15 ± 0.32
33.1**

Juniperus phoenicea
100
9.04 ± 0.89
15.4

200
7.77 ± 0.44
27.3*

Indomethacin
10
5.28 ± 0.26
50.6***

* ; ** ; *** significant from the control; SEM: standard error of the mean.

As shown in Table 2, topical application of the ointment prepared with the oils of aerial parts of J. oxycedrus subsp. oxycedrus and J. phoenicea onto the incised wounds demonstrated the best wound healing activity. On day 10 the tensile strength values were 31.5% and 36.3%, respectively. The rest of the oils did not show any remarkable wound healing activity.

The contraction values of vehicle, negative control, oils and reference drug treated groups were shown in Table 3. The oils obtained from the berries of J. oxycedrus subsp. oxycedrus and J. phoenicea were found to have wound healing potential, while the vehicle and negative control groups and the other oil ointments showed no statistically significant wound healing activity. The wound contractions were determined as 38.99% and 43.10% for J. oxycedrus subsp. oxycedrus and 33.28% and 40.74% for J. phoenicea when compared to reference drug Madecassol (90.78%–100%).

For the assessment of collagen synthesis hydroxyproline levels of treated tissues were evaluated. As shown in Table 4 significant increase in hydroxyproline content was observed for the tissues treated with the essential oils of J. oxycedrus ssp. oxycedrus and J. phoenicea.

Phases in wound healing processes (inflammation, proliferation, and remodeling) were observed and within the experimental groups with different degree (Table 5, Figures 1 and 2). The reference drug, essential oils of J. oxycedrus subsp. oxycedrus and J. phoenicea treated groups demonstrated faster remodeling respectively compared to the other groups which showed delayed wound healing processes. As an evidence of delay, wound-associated tissue debris still remained in the dermal tissues.

Figure 1: Histopathological view of wound healing and epidermal/dermal remodeling in the vehicle, negative control, oils, and reference ointment Madecassol-administered animals. Skin sections show the hematoxylin & eosin- (HE-) stained epidermis and dermis in A and the dermis stained with Van Gieson (VG) in B. The original magnification was ×100 and the scale bars represent 120 μm for figures in A, and the original magnification was ×400 and the scale bars represent 40 μm for B. Data are representative of 6 animals per group. (1) Vehicle group: 10-day-old wound tissue treated with only vehicle, (2) negative control group: 10-day-old wound tissue, untreated group, (3) C. sempervirens var. horizontalis group: 10-day-old wound tissue treated with the essential oil of C. sempervirens var. horizontalis, (4) C. sempervirens var. pyramidalis group, 10 day old wound tissue treated with essential oil of C. sempervirens var. pyramidalis, (5) J. communis group: 10-day-old wound tissue treated with essential oil of J. communis, (6) J. excelsa group: 10-day-old wound tissue treated with essential oil of J. excelsa, (7) J. foetidissima group: 10-day-old wound tissue treated with essential oil of J. foetidissima, (8) J. oxycedrus group: 10-day-old wound tissue treated with essential oil of J. oxycedrus, (9) J. phoenicea group: 10-day-old wound tissue treated with essential oil of J. phoenicea, and (10) reference group: 10-day-old wound tissue treated with Madecassol. Arrows pointing events during wound healing; s: scab, u: ulcer, re: re-epithelization, f: fibroblast, c: collagen, mnc: mononuclear cells, pmn: polymorphonuclear cells, and nv: neovascularization.

Figure 2: Healing phases of the vehicle, negative control, test ointments, and Madecassol-administered animals.

The effect of the extracts on the inflammatory phase of wound healing was examined by using the method of Whittle, based on the inhibition of acetic-acid-induced capillary permeability. As shown in Table 6, the inhibitory activity was observed for the oils from Juniperus oxycedrus ssp. oxycedrus and J. phoenicea at the dose of 200 mg/kg with the highest inhibitory values of 33.1% and 27.3%, respectively, while the essential oils from both species showed no significant effect at the dose of 100 mg/kg. On the other hand the rest of the oils did not show any inhibitory activity.

Previous studies revealed that the essential oils of Juniperus and Cupressus are rich in α-pinene. Particularly J. phoenicea possesses the highest α-pinene content compared to the other species in comparative phytochemical analysis; β-Pinene, sabinene, and limonene are the constituents which are also present in the essential oils of both genera [8, 10]. In a previous study, α-pinene was found to have moderate anti-inflammatory effect at 500 mg/kg dose on carrageenan-induced hind paw edema test [21]. Anti-inflammatory activity is essential for wound healing, since a long duration in the inflammatory phase causes a delay in healing process. In order to shorten the healing period as well as for minimal pain and scar, anti-inflammatory activity is required [22]. Presence of α-pinene in Juniperus species could probably contribute to wound healing activity by providing anti-inflammatory effect. Moreover, limonene is an important monoterpene which has a role in wound healing [23]. In a model of chronic skin inflammation, the researchers have also shown a significant effect of limonene and perillyl alcohol on skin repair and proinflammatory cytokines levels [24]. Furthermore, J. oxycedrus ssp. oxycedrus and J. phoenicea were found to have high flavonoid and phenolic acid content which provide them to show remarkable antioxidant activity [5]. As in many of the diseases, antioxidant activity also helps to promote wound healing process [25].

Collagen is an important extracellular matrix protein which provides strength and integrity to the tissue and plays an important role in haemostasis and epithelisation. High levels of hydroxyproline in regenerated tissue suggest enhanced collagen synthesis. Hence enhanced collagen synthesis by J. oxycedrus ssp. oxycedrus and J. phoenicea may significantly contribute to healing and provide strength to repaired tissue [18].

4. Conclusion

According to the experimental results, the oils from berries of J. oxycedrus ssp. oxycedrus and J. phoenicea were found to have better activity on the wound healing compared to the other essential oils and control groups. This might be due to the synergistic effect of the constituents present in the oils. This study provides a scientific evidence for the folkloric utilization of Juniperus for wound healing activity.

References

G. Topçu, R. Erenler, O. Çakmak et al., “Diterpenes from the berries of Juniperus excelsa,” Phytochemistry, vol. 50, no. 7, pp. 1195–1199, 1999.

I. Akinci, F. Ozdemir, A. Topuz, O. Kabas, and M. Canakci, “Some physical and nutritional properties of Juniperus drupacea fruits,” Journal of Food Engineering, vol. 65, no. 3, pp. 325–331, 2004.

P. Montagne, The Concise Larousse Gastronomique, Hamlyn, London, UK, 1999.

M. R. Loizzo, R. Tundis, F. Conforti, A. M. Saab, G. A. Statti, and F. Menichini, “Comparative chemical composition, antioxidant and hypoglycaemic activities of Juniperus oxycedrus ssp. oxycedrus L. berry and wood oils from Lebanon,” Food Chemistry, vol. 105, no. 2, pp. 572–578, 2007.

M. Öztürk, I. Tümen, A. Uğur, F. Aydoğmuş-Öztürk, and G. Topçu, “Evaluation of fruit extracts of six Turkish Juniperus species for their antioxidant, anticholinesterase and antimicrobial activities,” Journal of the Science of Food and Agriculture, vol. 91, no. 5, pp. 867–876, 2011.

P. A. Gadek, D. L. Alpers, M. M. Heslewood, and C. J. Quinn, “Relationships within Cupressaceae sensu lato: a combined morphological and molecular approach,” American Journal of Botany, vol. 87, no. 7, pp. 1044–1057, 2000.

E. Yeşilada, E. Sezik, G. Honda, Y. Takaishi, Y. Takeda, and T. Tanaka, “Traditional medicine in Turkey IX: folk medicine in north-west Anatolia,” Journal of Ethnopharmacology, vol. 64, no. 3, pp. 195–210, 1999.

I. Tumen, Türkiye’de Yetisen Juniperus spp. Türlerinin Igne Yaprak, Meyve ve Kozalaklarinin Kimyasal Bilesenleri, Doktora Tezi, Zonguldak Karaelmas Üniversitesi, Zonguldak, Turkey, 2005.

S. A. Emami, M. H. Khayyat, M. Rahimizadeh, S. B. Fazly-Bazzaz, and J. Assilia, “Chemical constituents of Cupressus sempervirens L. cv. Cereiformis Rehd. essential oils,” Iranian Journal of Pharmaceutical Sciences, vol. 1, no. 1, pp. 39–42, 2004.

I. Tumen, H. Hafizoglu, H. Kollmannsberger, B. Zimmermann, A. Keskiner, and H. C. Gultekin, “Essential oil of leaves Juniperus ssp. Natively grown in Turkey,” Pharmacognosy Magazine, vol. 6, pp. 22–137, 2010.

I. Tümen and M. Reunanen, “A comparative study on turpentine oils of oleoresins of Pinus sylvestris L. from three districts of Denizli,” Records of Natural Products, vol. 4, no. 4, pp. 224–229, 2010.

I. Tumen, H. Hafizoglu, A. Pranovich, and M. Reunanen, “Chemical constituents of cones and leaves of cypress (Cupressus sempervirens L.) grown in Turkey,” Fresenius Environmental Bulletin, vol. 19, no. 10, pp. 2268–2276, 2010.

B. S. Shetty, S. L. Udupa, A. L. Udupa, and S. N. Somayaji, “Effect of Centella asiatica L (Umbelliferae) on normal and dexamethasone-suppressed wound healing in Wistar albino rats,” International Journal of Lower Extremity Wounds, vol. 5, no. 3, pp. 137–143, 2006.

S. Lodhi, R. S. Pawar, A. P. Jain, and A. K. Singhai, “Wound healing potential of Tephrosia purpurea (Linn.) Pers. in rats,” Journal of Ethnopharmacology, vol. 108, no. 2, pp. 204–210, 2006.

L. Suguna, S. Singh, P. Sivakumar, P. Sampath, and G. Chandrakasan, “Influence of Terminalia chebula on dermal wound healing in rats,” Phytotherapy Research, vol. 16, no. 3, pp. 227–231, 2002.

F. Sadaf, R. Saleem, M. Ahmed, S. I. Ahmad, and Navaid-ul-Zafar, “Healing potential of cream containing extract of Sphaeranthus indicus on dermal wounds in Guinea pigs,” Journal of Ethnopharmacology, vol. 107, no. 2, pp. 161–163, 2006.

J. F. Woessner, “The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid,” Archives of Biochemistry and Biophysics, vol. 93, no. 2, pp. 440–447, 1961.

A. M. Rasik, R. Raghubir, A. Gupta et al., “Healing potential of Calotropis procera on dermal wounds in Guinea pigs,” Journal of Ethnopharmacology, vol. 68, no. 1–3, pp. 261–266, 1999.

B. A. Whittle, “The use of changes in capillary permeability in mice to distinguish between narcotic and non-narcotic analgesics,” British Journal of Pharmacology and Chemotherapy, vol. 22, pp. 246–253, 1964.

E. Yesilada and E. Küpeli, “Clematis vitalba L. aerial part exhibits potent anti-inflammatory, antinociceptive and antipyretic effects,” Journal of Ethnopharmacology, vol. 110, no. 3, pp. 504–515, 2007.

I. Orhan, E. Küpeli, M. Aslan, M. Kartal, and E. Yesilada, “Bioassay-guided evaluation of anti-inflammatory and antinociceptive activities of pistachio, Pistacia vera L,” Journal of Ethnopharmacology, vol. 105, no. 1-2, pp. 235–240, 2006.

R. A. F. Clark, Cutaneous Wound Repair, Oxford University, New York, NY, USA, 1991.

S. Adams and T. P. Thrash, “Methods for wound treatment and healing using limonene-based compositions,” International Application WO2010/062933 A1, Patent Cooperation Treaty, 2010.

P. L. Stanley, S. Steiner, M. Havens, and K. M. Tramposch, “Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate,” Skin Pharmacology, vol. 4, no. 4, pp. 262–271, 1991.

I. Pesin, U. Koca, H Keleş, and E. K. Akkol, “Wound healing activity of Rubus sanctus Schreber (Rosaceae): preclinical study in animal models,” Evidence Based Complementary and Alternative Medicine, vol. 2011, Article ID 816156, 6 pages, 2011.